For the Love of Science – How Parents Within the Industry Are Helping to Shape the Next Generation of Science Lovers

Published on :

For the Love of Science – How Parents Within the Industry Are Helping to Shape the Next Generation of Science Lovers By Cat Thoreson | February 1, 2024 Before I [….]

Weekly Quick Hits (BioHealth Capital Region) – Week of May 15, 2023

Published on :

Weekly Quick Hits (BioHealth Capital Region) – Week of May 15, 2023 By Alex Keown and Sarah EllinwoodMay 19, 2023 Funding, Awards and Collaborations PQE Group US Earns 2023 Great [….]

BioHealth Capital Region Q1 2023 News Recap – We Get Knocked Down, But We Get Up Again

Published on :

BioHealth Capital Region Q1 2023 News Recap – We Get Knocked Down, But We Get Up Again By Sarah EllinwoodApril 11, 2023 Now that I got that 90s earworm in [….]

Here Are Several Philly-Area Life Science Companies Hiring Right Now: Q2 2023

Published on :

The Philadelphia region, which includes Delaware and Southern New Jersey, is emerging as one of the top areas in the U.S. for the life sciences. So-called “Cellicon Valley” has numerous top academic institutions, and a range of biopharma companies working in drug discovery and development, as well as contract research organizations that manufacture and help deliver drugs. BioBuzz rounds up some of the leading companies in the region looking for top talent, with examples of a few of the jobs they’re currently hiring for.

Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate

Published on :

Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its Phase 1 study evaluating the safety and immunogenicity of EBS-LASV, a recombinant VSV-vectored Lassa virus vaccine candidate being developed for prevention of disease caused by Lassa virus infection. Emergent and CEPI (the Coalition for Epidemic Preparedness Innovations) are co-funding this program.

Top Biotech Companies Hiring in Maryland: Summer 2022 Edition

Published on :

Here’s our Summer 2022 Roundup of top Maryland life sciences companies with more than 10 active job listings across a wide range of fields and experience levels. 

Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola

Published on :

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeback Bio”), a biotechnology company focused on emerging infectious diseases, intended to create a collaboration to expand the availability of Ebanga™ (Ansuvimab-zykl). Under the terms of the contemplated collaboration, Emergent will be responsible for the manufacturing, sale, and distribution of Ebanga™ in the United States and Canada, and Ridgeback Bio will serve as the global access partner for Ebanga™, ensuring it remains available to patients in endemic countries free of charge through Ridgeback Bio’s compassionate use program. Ebanga™ was approved by the U.S. Food and Drug Administration (FDA) in December 2020 for the treatment of Ebola.

Emergent BioSolutions Founder Fuad El-Hibri Dies Weeks After Retirement

Published on :

Emergent BioSolutions Founder Fuad El-Hibri Dies Weeks After Retirement
Published: May 02, 2022 By Alex Keown
Fuad El-Hibri/Courtesy of The Washington Post/Getty Images
Weeks after stepping down from his role as executive chairman of Emergent BioSolutions, company founder and former chief executive officer Fuad El-Hibri has died.
In a brief statement issued by Maryland-based Emergent, El-Hibri died at home last week died at his home, surrounded by family. No cause of death was provided by the company, however, The New York Times reported that the cause of death was related to pancreatic cancer. El-Hibri was 64.
El-Hibri stepped down from his role as executive chairman on April 1. He initially announced his decision at the beginning of the year.
“Creating and leading Emergent has been the honor of my life, and it would not have been possible without the help of our incredible team,” El-Hibri said in a statement when he announced his retirement. “I want to thank everyone at Emergent, past and present, for helping advance our inspiring mission over the past two decades. I could never have imagined the number of lives we would impact, and I will forever be proud of our accomplishments. Emergent is on track…